MHealth for Antiretroviral adherence
Phase 3
- Conditions
- HIV.Human immunodeficiency virus [HIV] disease
- Registration Number
- IRCT20100601004076N23
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
All PLHIV will be eligible to participate if they are receiving ART
aged 18 years or above
own or have sufficient access to a mobile phone
are able to sufficiently operate a cell phone to communicate using mobile-messaging (help by a partner is sufficient for patients with reading and/or writing difficulties)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence to HIV treatment. Timepoint: Every week. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Vira Load. Timepoint: At the end of intervention. Method of measurement: Lab Test.;CD4 Cell Count. Timepoint: At the end of the intervention. Method of measurement: Lab test.